Friday, 31 May 2019

Cervical Cancer

Overview

Cervical cancer is a type of cancer that occurs in the cells of the cervix — the lower part of the uterus that connects to the vagina.
Various strains of the human papillomavirus (HPV), a sexually transmitted infection, play a role in causing most cervical cancer.
When exposed to HPV, a woman's immune system typically prevents the virus from doing harm. In a small group of women, however, the virus survives for years, contributing to the process that causes some cells on the surface of the cervix to become cancer cells.
You can reduce your risk of developing cervical cancer by having screening tests and receiving a vaccine that protects against HPV infection.

Symptoms

Early-stage cervical cancer generally produces no signs or symptoms.
Signs and symptoms of more-advanced cervical cancer include:
  • Vaginal bleeding after intercourse, between periods or after menopause
  • Watery, bloody vaginal discharge that may be heavy and have a foul odor
  • Pelvic pain or pain during intercourse

When to see a doctor

Make an appointment with your doctor if you have any signs or symptoms that concern you.

Causes

Cervical cancer begins when healthy cells acquire a genetic change (mutation) that causes them to turn into abnormal cells.
Healthy cells grow and multiply at a set rate, eventually dying at a set time. Cancer cells grow and multiply out of control, and they don't die. The accumulating abnormal cells form a mass (tumor). Cancer cells invade nearby tissues and can break off from a tumor to spread (metastasize) elsewhere in the body.
It isn't clear what causes cervical cancer, but it's certain that HPV plays a role. HPV is very common, and most women with the virus never develop cervical cancer. This means other factors — such as your environment or your lifestyle choices — also determine whether you'll develop cervical cancer.

Types of cervical cancer

The type of cervical cancer that you have helps determine your prognosis and treatment. The main types of cervical cancer are:
  • Squamous cell carcinoma. This type of cervical cancer begins in the thin, flat cells (squamous cells) lining the outer part of the cervix, which projects into the vagina. Most cervical cancers are squamous cell carcinomas.
  • Adenocarcinoma. This type of cervical cancer begins in the column-shaped glandular cells that line the cervical canal.
Sometimes, both types of cells are involved in cervical cancer. Very rarely, cancer occurs in other cells in the cervix.

Risk factors

Risk factors for cervical cancer include:
  • Many sexual partners. The greater your number of sexual partners — and the greater your partner's number of sexual partners — the greater your chance of acquiring HPV.
  • Early sexual activity. Having sex at an early age increases your risk of HPV.
  • Other sexually transmitted infections (STIs). Having other STIs — such as chlamydia, gonorrhea, syphilis and HIV/AIDS — increases your risk of HPV.
  • A weak immune system. You may be more likely to develop cervical cancer if your immune system is weakened by another health condition and you have HPV.
  • Smoking. Smoking is associated with squamous cell cervical cancer.

Prevention

To reduce your risk of cervical cancer:
  • Get vaccinated against HPV.Vaccination is available for girls and women ages 9 to 26. The vaccine is most effective if given to girls before they become sexually active.
  • Have routine Pap tests. Pap tests can detect precancerous conditions of the cervix, so they can be monitored or treated in order to prevent cervical cancer. Most medical organizations suggest women begin routine Pap tests at age 21 and repeat them every few years.
  • Practice safe sex. Using a condom, having fewer sexual partners and delaying intercourse may reduce your risk of cervical cancer.
  • Don't smoke.

Revised FIGO staging for cervical cancer 2018

Stage I:
The carcinoma is strictly confined to the cervix uteri (extension to the corpus should be disregarded)
  • IA Invasive carcinoma that can be diagnosed only by microscopy, with maximum depth of invasion <5 mma
    • IA1 Measured stromal invasion <3 mm in depth
    • IA2 Measured stromal invasion ≥3 mm and <5 mm in depth
  • IB Invasive carcinoma with measured deepest invasion ≥5 mm (greater than stage IA), lesion limited to the cervix uterib
    • IB1 Invasive carcinoma ≥5 mm depth of stromal invasion and <2 cm in greatest dimension
    • IB2 Invasive carcinoma ≥2 cm and <4 cm in greatest dimension
    • IB3 Invasive carcinoma ≥4 cm in greatest dimension
Stage II:
The carcinoma invades beyond the uterus, but has not extended onto the lower third of the vagina or to the pelvic wall
  • IIA Involvement limited to the upper two‐thirds of the vagina without parametrial involvement
    • IIA1 Invasive carcinoma <4 cm in greatest dimension
    • IIA2 Invasive carcinoma ≥4 cm in greatest dimension
  • IIB With parametrial involvement but not up to the pelvic wall
Stage III:
The carcinoma involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or non‐functioning kidney and/or involves pelvic and/or paraaortic lymph nodesc
  • IIIA Carcinoma involves the lower third of the vagina, with no extension to the pelvic wall
  • IIIB Extension to the pelvic wall and/or hydronephrosis or non‐functioning kidney (unless known to be due to another cause)
  • IIIC Involvement of pelvic and/or paraaortic lymph nodes, irrespective of tumor size and extent (with r and p notations)c
    • IIIC1 Pelvic lymph node metastasis only
    • IIIC2 Paraaortic lymph node metastasis
Stage IV:
The carcinoma has extended beyond the true pelvis or has involved (biopsy proven) the mucosa of the bladder or rectum. A bullous edema, as such, does not permit a case to be allotted to stage IV
  • IVA Spread of the growth to adjacent organs
  • IVB Spread to distant organs